Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001477932-25-002606
Filing Date
2025-04-10
Accepted
2025-04-10 21:39:07
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 7572
  Complete submission text file 0001477932-25-002606.txt   9035
Mailing Address STERN AEGIS VENTURES 810 7TH AVENUE 22ND FLOOR NEW YORK NY 10019
Business Address
STERN ADAM K (Reporting) CIK: 0001403497 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38022 | Film No.: 25829643

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)